Guillian Barré syndrome--recent advances.
Guillian Barré Syndrome (GBS) is an acquired disease of the peripheral nerves that is characterized clinically by rapidly progressing paralysis, areflexia, and albumino-cytological dissociation. It affects both genders, involves people of all ages, is reported worldwide, and in the post-polio era, it is the most common cause of an acute generalized paralysis. The clinical features are distinct and a history and an examination generally lead to a high suspicion of the diagnosis that can then be confirmed by supportive laboratory tests and electrodiagnostic studies. This review discusses the recent advances in understanding of the different variants of GBS such as acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy (AMAN), acute motor sensory axonal neuropathy (AMSAN), and the Fisher syndrome. The clinical, electrodiagnostic criteria, immunopathogenesis, and management of GBS and its variants are discussed.
Vedanarayanan
V V
VV
Department of Neurology, University of Mississippi School of Medicine, Jackson, USA.
Chaudhry
V
V
D003937:Diagnosis, Differential; D004568:Electrodiagnosis; D004594:Electrophysiology; D020275:Guillain-Barre Syndrome / Q000145:classification / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D019846:Miller Fisher Syndrome / Q000175:diagnosis / Q000628:therapy; D011379:Prognosis
D016756:Immunoglobulins, Intravenous